MENA 2024 Recordings-Hypercalcemia

Video Transcription

Video Summary

The presentation in Dubai by an esteemed endocrinologist focused on hypercalcemia, highlighting both straightforward and complex cases. Significant emphasis was placed on emerging complexities in treatment and diagnosis advancements. The main points covered included the importance of timely information dissemination among practitioners, details on calcium metabolism, physiological impacts of hypercalcemia, and calcium testing intricacies. Various hypercalcemia cases revealed possible misdiagnosis pitfalls, such as familial hypocalciuric hypercalcemia and genetic mutations like CYP24A1 deficiency, which can affect vitamin D metabolism. The presentation also touched on treatment considerations for immobilized patients, such as astronauts experiencing microgravity, to prevent hypercalcemia. Emerging concerns include certain medications like denosumab and excessive vitamin D causing hypercalcemia. The lecture concluded by discussing the diagnostic challenges of normocalcemic primary hyperparathyroidism, urging cautious interpretation and appropriate surgical interventions.

Asset Subtitle

Dr. Steven Petak

Keywords

hypercalcemia

calcium metabolism

diagnosis advancements

familial hypocalciuric hypercalcemia

CYP24A1 deficiency

normocalcemic primary hyperparathyroidism